| Dr Justin Todd Davis, MD | |
|
4000 Cambridge St, Kansas City, KS 66160-8501 | |
| (913) 588-9900 | |
| (913) 299-9542 |
| Full Name | Dr Justin Todd Davis |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 22 Years |
| Location | 4000 Cambridge St, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487817946 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | R1659 (Kentucky) | Secondary |
| 207T00000X | Neurological Surgery | 0436378 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Freeman Health System - Freeman West | Joplin, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Fidelitas Medical IT-Solutions, LP announced today the launch of their product DDS, a dispensing and documentation system for methadone treatment.
Hundreds of types of mitochondrial disease affect up to 38 million people worldwide, yet there are very few effective treatments, forcing patients and doctors to rely on symptom management to battle the serious and potentially fatal genetic disorder that starves the body's cells of energy.
Bristol-Myers Squibb Company today announced results from a Phase II clinical trial in which treatment with the investigational direct-acting antiviral BMS-790052, an NS5A replication complex inhibitor, in combination with PEG-Interferon alfa and ribavirin, achieved sustained virologic response 12 weeks post-treatment in up to 92% of treatment-naïve patients chronically infected with hepatitis C genotype 1.
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia may produce long-term pain relief.
› Verified 8 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Fidelitas Medical IT-Solutions, LP announced today the launch of their product DDS, a dispensing and documentation system for methadone treatment.
Hundreds of types of mitochondrial disease affect up to 38 million people worldwide, yet there are very few effective treatments, forcing patients and doctors to rely on symptom management to battle the serious and potentially fatal genetic disorder that starves the body's cells of energy.
Bristol-Myers Squibb Company today announced results from a Phase II clinical trial in which treatment with the investigational direct-acting antiviral BMS-790052, an NS5A replication complex inhibitor, in combination with PEG-Interferon alfa and ribavirin, achieved sustained virologic response 12 weeks post-treatment in up to 92% of treatment-naïve patients chronically infected with hepatitis C genotype 1.
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia may produce long-term pain relief.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Todd Davis, MD 4000 Cambridge St, Kansas City, KS 66160-8501 Ph: (913) 588-9900 | Dr Justin Todd Davis, MD 4000 Cambridge St, Kansas City, KS 66160-8501 Ph: (913) 588-9900 |
News Archive
Fidelitas Medical IT-Solutions, LP announced today the launch of their product DDS, a dispensing and documentation system for methadone treatment.
Hundreds of types of mitochondrial disease affect up to 38 million people worldwide, yet there are very few effective treatments, forcing patients and doctors to rely on symptom management to battle the serious and potentially fatal genetic disorder that starves the body's cells of energy.
Bristol-Myers Squibb Company today announced results from a Phase II clinical trial in which treatment with the investigational direct-acting antiviral BMS-790052, an NS5A replication complex inhibitor, in combination with PEG-Interferon alfa and ribavirin, achieved sustained virologic response 12 weeks post-treatment in up to 92% of treatment-naïve patients chronically infected with hepatitis C genotype 1.
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia may produce long-term pain relief.
› Verified 8 days ago
Anne F Stanton, ARNP Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Dept. Of Neurosurgery, Mail Stop 3021, Kansas City, KS 66160 Phone: 913-588-6180 Fax: 913-588-7570 | |
Dr. Joseph Domino, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-6119 | |
Bailey Raine Yekzaman, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 3021, Kansas City, KS 66160 Phone: 913-588-1227 | |
Dr. Jean-luc Kalonda Kabangu, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Dr. Sarah Isobel Woodrow, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-6125 Fax: 913-588-7570 | |
Jules M Nazzaro, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-5129 Fax: 913-588-5337 | |
Jeremy Charles Peterson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: University Of Kansas Hospital School Of, Dept. Of Neurosurgery, 3901 Rainbow Blvd., Ms 3021, Kansas City, KS 66160 Phone: 913-588-6119 Fax: 913-588-7570 |